GENTIAL PSORIASIS

CLINICAL TRIAL | the abstract

Principal Investigator: Dr. Jennifer Cather

A multi-center, randomized, double-blind study comparing the efficacy and safety of Taltz® (Ixekizumab) versus placebo in patients with moderate-to-severe genital psoriasis.

Psoriasis involves the genitalia in two-thirds of patients over the course of their lifetime. Genital psoriasis can affect the quality of life physically due to itching, burning, bleeding, as well as emotional well-being due to isolation and embarrassment. Genital psoriasis may worsen with sexual interactions and often limit not only the quantity but quality of sex. Taltz® (Ixekizumab) is a safe and effective therapy for genital psoriasis.

SOTA Formula Consideration Based on Data:

Both topical and oral CBD may be beneficial to patients. There are case reports of topical CBD improving psoriasis.  Oral use of CBD may help with itch and pain associated with the disease. 

Learn more about the benefits of SOTA Tinctures and Ice. Topical and oral CBD helps treat psoriasis. There are case reports of topical CBD improving psoriasis. SOTA Ice is a topical pain and muscle gel which includes CBD and Menthol which may improve arthritis symptoms.

 

Study dates: 2016-2018